Sutro Biopharma, Inc. (NASDAQ:STRO) Financings

Sutro Biopharma, Inc.

Financings

RaiseDate
Public offering of common stock
Announced: about US$110M · US$13.98 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), LifeSci Capital (co-lead)
Buyers: BVF Partners L.P.; Samsara BioCapital; Coastlands Capital; Eventide Asset Management; Perceptive Advisors; RA Capital Management; ADAR1 Capital Management; Affinity Asset Advisors; Acuta Capital Partners
Use of proceeds: General corporate purposes, including research, clinical and process development and manufacturing of product candidates, and working capital
Feb 10, 2026

Read by 6ix AI from the company's releases